Annual Total Long Term Liabilities
$103.52 M
-$27.93 M-21.25%
31 December 2023
Summary:
Tango Therapeutics annual total long term liabilities is currently $103.52 million, with the most recent change of -$27.93 million (-21.25%) on 31 December 2023. During the last 3 years, it has fallen by -$24.21 million (-18.96%). TNGX annual total long term liabilities is now -21.25% below its all-time high of $131.45 million, reached on 31 December 2022.TNGX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$85.66 M
-$4.25 M-4.73%
30 September 2024
Summary:
Tango Therapeutics quarterly total long term liabilities is currently $85.66 million, with the most recent change of -$4.25 million (-4.73%) on 30 September 2024. Over the past year, it has dropped by -$22.52 million (-20.81%). TNGX quarterly long term liabilities is now -38.71% below its all-time high of $139.76 million, reached on 30 September 2022.TNGX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.3% | -20.8% |
| 3 y3 years | -19.0% | -30.2% |
| 5 y5 years | - | - |
TNGX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.3% | at low | -38.7% | at low |
| 5 y | 5 years | -21.3% | at low | -38.7% | at low |
| alltime | all time | -21.3% | at low | -38.7% | at low |
Tango Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $85.66 M(-4.7%) |
| June 2024 | - | $89.91 M(-9.2%) |
| Mar 2024 | - | $98.98 M(-4.4%) |
| Dec 2023 | $103.52 M(-21.2%) | $103.52 M(-4.3%) |
| Sept 2023 | - | $108.18 M(-4.1%) |
| June 2023 | - | $112.75 M(-8.2%) |
| Mar 2023 | - | $122.84 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $131.45 M(+14.6%) | $131.45 M(-5.9%) |
| Sept 2022 | - | $139.76 M(+33.1%) |
| June 2022 | - | $105.01 M(-6.2%) |
| Mar 2022 | - | $111.96 M(-2.4%) |
| Dec 2021 | $114.72 M(-10.2%) | $114.72 M(-6.5%) |
| Sept 2021 | - | $122.74 M(-3.9%) |
| Dec 2020 | $127.73 M | $127.73 M |
FAQ
- What is Tango Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Tango Therapeutics?
- What is Tango Therapeutics annual total long term liabilities year-on-year change?
- What is Tango Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Tango Therapeutics?
- What is Tango Therapeutics quarterly long term liabilities year-on-year change?
What is Tango Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TNGX is $103.52 M
What is the all time high annual total long term liabilities for Tango Therapeutics?
Tango Therapeutics all-time high annual total long term liabilities is $131.45 M
What is Tango Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TNGX annual total long term liabilities has changed by -$27.93 M (-21.25%)
What is Tango Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TNGX is $85.66 M
What is the all time high quarterly long term liabilities for Tango Therapeutics?
Tango Therapeutics all-time high quarterly total long term liabilities is $139.76 M
What is Tango Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TNGX quarterly total long term liabilities has changed by -$22.52 M (-20.81%)